ConductScience.org, home

Paper355604

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.

Walker MD and 11 others. J Neurosurg, 1978. Cited by 1,405 papers, by iCite.

Cite this record

ConductScience Library. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. Papers, record 355604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/355604

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.
PubMed
Journal
J Neurosurg
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
1,405
iCite
Relative citation ratio, by iCite
36.7
iCite
Revised in PubMed
2022-04-09
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Walker MDM D
2Alexander E JrE
3Hunt WEW E
4MacCarty CSC S
5Mahaley MS JrM S
6Mealey J JrJ
7Norrell HAH A
8Owens GG
9Ransohoff JJ
10Wilson CBC B
11Gehan EAE A
12Strike TAT A

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Brain NeoplasmsMajor topic
CarmustineMajor topic
GliomaMajor topic
Adolescent
Adult
Aged
Child
Clinical Trials as Topic
Evaluation Studies as Topic
Female
Humans
Male
Middle Aged

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT06831773Clinical Study of Carbon Ion Radiotherapy for High-grade GliomaBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by432

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,405 citations.

PMIDTitleJournalYearIn PapersSource
42506372When Surgical Innovation Outpaces Evidence: Does Modern Maximal Resection Require Re-Evaluation of Postoperative Radiotherapy in Glioblastoma?Med Sci (Basel)2026https://conductscience.org/library/papers/42506372PubMed
42465896Phase I dose escalation of the Exportin 1 inhibitor, Selinexor, in combination with chemoradiation in patients with newly diagnosed glioblastoma.medRxiv2026https://conductscience.org/library/papers/42465896PubMed
42286261Spatial-temporal recurrence patterns of grade 4 glioma using deep learning integrated multiparametric MRI and molecular pathology.NPJ Precis Oncol2026https://conductscience.org/library/papers/42286261PubMed
42281979DNA-PKcs inhibition sensitizes glioblastoma to radiotherapy through reprogramming of tumor cell states and immune microenvironment cell types.Res Sq2026https://conductscience.org/library/papers/42281979PubMed
42222273The evolution of chemotherapy in brain tumors: from historical milestones to precision medicine in glioblastoma.Explor Target Antitumor Ther2026https://conductscience.org/library/papers/42222273PubMed
42111034Comparative analysis of outcome, recurrence patterns, and dosimetry in glioblastoma patients treated according to RTOG versus EORTC contouring guidelines.Neurooncol Pract2026https://conductscience.org/library/papers/42111034PubMed
42031827Prognostic determinants and predictive modeling in higher-grade glioma patients receiving radiotherapy: a retrospective SEER-based study.Sci Rep2026https://conductscience.org/library/papers/42031827PubMed
41851195NANP targeting radiosensitizes glioblastoma through TNFR1 sialylation-driven mesenchymal shift.Nat Commun2026https://conductscience.org/library/papers/41851195PubMed
41684714Innovative radiotherapies for the treatment of glioblastoma.Neurooncol Adv2026https://conductscience.org/library/papers/41684714PubMed
41632520Reply to: Blood-Brain Barrier Heterogeneity in NRG BN007: Implications for Immunotherapy Delivery.J Clin Oncol2026https://conductscience.org/library/papers/41632520PubMed
41501375The functional imperative in high-grade glioma.Exp Mol Med2026https://conductscience.org/library/papers/41501375PubMed
40985888Tumor heterogeneity underlies clinical outcome and MEK inhibitor response in somatic NF1-mutant glioblastoma.JCI Insight2025https://conductscience.org/library/papers/40985888PubMed
40867234The Effects of Radiation Therapy on the Ocular Apparatus: Implications for Management.Cancers (Basel)2025https://conductscience.org/library/papers/40867234PubMed
40852066Comparison of Quality of Life in Postoperative High-Grade Glioma Patients Treated Using EORTC and RTOG Target Delineation Techniques for Postoperative Radiotherapy.Asian J Neurosurg2025https://conductscience.org/library/papers/40852066PubMed
39595047Amino Acid Deprivation in Glioblastoma: The Role in Survival and the Tumour Microenvironment-A Narrative Review.Biomedicines2024https://conductscience.org/library/papers/39595047PubMed
39468721Sleep disorders associated with cranial radiation-A systematic review.Neuro Oncol2025https://conductscience.org/library/papers/39468721PubMed
39375777In vivo perturb-seq of cancer and microenvironment cells dissects oncologic drivers and radiotherapy responses in glioblastoma.Genome Biol2024https://conductscience.org/library/papers/39375777PubMed
39239570A systematic review of normal tissue neurovascular unit damage following brain irradiation-Factors affecting damage severity and timing of effects.Neurooncol Adv2024https://conductscience.org/library/papers/39239570PubMed
38994761Targeting drug resistance in glioblastoma (Review).Int J Oncol2024https://conductscience.org/library/papers/38994761PubMed
38899374Current status of precision oncology in adult glioblastoma.Mol Oncol2024https://conductscience.org/library/papers/38899374PubMed

See all 432 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/355604

GET https://conductscience.org/api/papers/v1/355604/cited_by?page=2